Valuations remain elevated but are expected to normalize as earnings growth catches up. The market may not see the PE expansion witnessed earlier; rather, it could trade in a narrower PE range of 18x-22x, depending on how corporate earnings evolve.
Valuations remain elevated but are expected to normalize as earnings growth catches up. The market may not see the PE expansion witnessed earlier; rather, it could trade in a narrower PE range of 18x-22x, depending on how corporate earnings evolve.